Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: The lower mortality rate of obese patients with heart failure (HF) has been partly attributed to reverse causation bias due to weight loss caused by disease. Using data about weight both before and after HF, this study aimed to adjust for reverse causation and examine the association of obesity both before and after HF with mortality. METHODS: Using the Atherosclerosis Risk in Communities (ARIC) study, 308 patients with data available from before and after the incidence of HF were included. Pre-morbid and post-morbid obesity were defined based on body mass index measurements at least three months before and after incident HF. The associations of pre-morbid and post-morbid obesity and weight change with survival after HF were evaluated using a Cox proportional hazard model. RESULTS: Pre-morbid obesity was associated with higher mortality (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.04 to 2.49) but post-morbid obesity was associated with increased survival (HR, 0.57; 95% CI, 0.37 to 0.88). Adjusting for weight change due to disease as a confounder of the obesity-mortality relationship resulted in the absence of any significant associations between post-morbid obesity and mortality. CONCLUSIONS: This study demonstrated that controlling for reverse causality by adjusting for the confounder of weight change may remove or reverse the protective effect of obesity on mortality among patients with incident HF.
Abstract
OBJECTIVES: The lower mortality rate of obese patients with heart failure (HF) has been partly attributed to reverse causation bias due to weight loss caused by disease. Using data about weight both before and after HF, this study aimed to adjust for reverse causation and examine the association of obesity both before and after HF with mortality. METHODS: Using the Atherosclerosis Risk in Communities (ARIC) study, 308 patients with data available from before and after the incidence of HF were included. Pre-morbid and post-morbid obesity were defined based on body mass index measurements at least three months before and after incident HF. The associations of pre-morbid and post-morbid obesity and weight change with survival after HF were evaluated using a Cox proportional hazard model. RESULTS: Pre-morbid obesity was associated with higher mortality (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.04 to 2.49) but post-morbid obesity was associated with increased survival (HR, 0.57; 95% CI, 0.37 to 0.88). Adjusting for weight change due to disease as a confounder of the obesity-mortality relationship resulted in the absence of any significant associations between post-morbid obesity and mortality. CONCLUSIONS: This study demonstrated that controlling for reverse causality by adjusting for the confounder of weight change may remove or reverse the protective effect of obesity on mortality among patients with incident HF.
참고문헌 (28)
- Berrington de Gonzalez A, "Body-mass index and mortality among 1.46 million white adults", N Engl J Med, 363, pp.2211~2219 (2010)
- Flegal KM, "Association of all-cause mortality with overweight and obesity using standard body mass index categories : a systematic review and meta-analysis", JAMA, 309, pp.71~82 (2013)
- Uretsky S, "Obesity paradox in patients with hypertension and coronary artery disease", Am J Med, 120, pp.863~870 (2007)
- Sharma A, "Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure", Am J Cardiol, 115, pp.1428~1434 (2015)
- Oreopoulos A, "Body mass index and mortality in heart failure : a meta-analysis", Am Heart J, 156, pp.13~22 (2008)
- Shah R, "Body mass index and mortality in acutely decompensated heart failure across the world : a global obesity paradox", J Am Coll Cardiol, 63, pp.778~785 (2014)
- Kenchaiah S, "Body mass index and prognosis in patients with chronic heart failure : insights from the candesartan in heart failure : assessment of reduction in mortality and morbidity(CHARM)program", Circulation, 116, pp.627~636 (2007)
- Anker SD, "Wasting as independent risk factor for mortality in chronic heart failure", Lancet, 349, pp.1050~1053 (1997)
- Banack HR, "The obesity paradox : understanding the effect of obesity on mortality among individuals with cardiovascular disease", Prev Med, 62, pp.96~102 (2014)
- Anker SD, "Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors : an observational study", Lancet, 361, pp.1077~1083 (2003)
- Doehner W, "Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity : an analysis of the PROactive study population", Int J Cardiol, 162, pp.20~26 (2012)
- Pocock SJ, "Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure : assessment of reduction in mortality and morbidity(CHARM)programme", Eur Heart J, 29, pp.2641~2650 (2008)
- Adams KF, "Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old", N Engl J Med, 355, pp.763~778 (2006)
- Flanders WD, "Adjusting for reverse causality in the relationship between obesity and mortality", Int J Obes (Lond), 32(Suppl 3), pp.S42~S46 (2008)
- Flegal KM, "Reverse causation and illness-related weight loss in observational studies of body weight and mortality", Am J Epidemiol, 173, pp.1~9 (2011)
- Janssen I, "Effect of current and midlife obesity status on mortality risk in the elderly", Obesity(Silver Spring), 16, pp.2504~2509 (2008)
- Lawlor DA, "Reverse causality and confounding and the associations of overweight and obesity with mortality", Obesity(Silver Spring), 14, pp.2294~2304 (2006)
- Stokes A, "Using maximum weight to redefine body mass index categories in studies of the mortality risks of obesity", Popul Health Metr, 12, pp.6~ (2014)
- Lewis CE, "Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association", Circulation, 119, pp.3263~3271 (2009)
- Robins JM, "Causal models for estimating the effects of weight gain on mortality", Int J Obes (Lond), 32(Suppl 3), pp.S15~S41 (2008)
- ARIC Investigators, "The Atherosclerosis Risk in Communities (ARIC) study: design and objectives", Am J Epidemiol, 129, pp.687~702 (1989)
- Lavie CJ, "The obesity paradox, weight loss, and coronary disease", Am J Med, 122, pp.1106~1114 (2009)
- Strandberg TE, "Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men", Eur Heart J, 30, pp.1720~1727 (2009)
- Myers J, "The obesity paradox and weight loss", Am J Med, 124, pp.924~930 (2011)
- Kennedy LM, "Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease", Eur Heart J, 27, pp.2755~2762 (2006)
- Khalid U, "Pre-morbid body mass index and mortality after incident heart failure : the ARIC study", J Am Coll Cardiol, 64, pp.2743~2749 (2014)
- Ferreira I, "Obesity paradox or inappropriate study designs? Time for life-course epidemiology", J Hypertens, 30, pp.2271~2275 (2012)
- Rosamond WD, "Classification of heart failure in the Atherosclerosis Risk in Communities(ARIC)study : a comparison of diagnostic criteria", Circ Heart Fail, 5, pp.152~159 (2012)